Additionally, recent studies suggest that the use of Gal-3 inhibitory proteins could be a promising strategy to prevent myocardial fibrosis and reduce the incidence of heart failure after myocardial infarction [95]. This evidence concerns the gene LGALS3 and Myocardial fibrosis.